EROAD's FCF jumped to $16.0m on a capex halving, not on stronger operating cash

What changed

Revenue rose 6.8% to $194.4m and EBITDA climbed 11.8% to $59.6m, with operating profit expanding to $5.9m from $0.8m. Profit before tax swung to a $0.2m profit from a $7.0m loss, and NPAT printed $1.4m versus a $0.3m loss. Below the line, operating cash flow fell 18.3% to $43.2m, but capex dropped to $13.4m from $32.2m — taking capex-to-revenue from 17.7% to 6.9% — lifting company-defined free cash flow (to the firm) to $16.0m from $1.3m. Gross borrowings reduced to $25.6m from $36.6m, and net debt approximately halved to $11.8m, with net debt/EBITDA easing from roughly 0.4x to 0.2x. At the segment level, New Zealand revenue grew from $92.0m to $103.9m while holding a ~67% EBITDA margin; North America grew modestly but margin compressed from ~27.5% to ~21.8%; Corporate & Development remained loss-making at -$31.6m.

What matters

• Cash conversion deteriorated materially. OCF/EBITDA fell from 99.2% to 72.5%. The headline FCF improvement is entirely driven by a $18.8m step-down in capex (linked to the 4G upgrade program cycle), not by stronger operating cash generation. The "normalised for 4G" FCF disclosed at $23.6m makes the point that the underlying run-rate depends heavily on how investment intensity rebases.
• North American margin compression. North America is the second-largest segment, and segment EBITDA margin fell roughly 570 basis points to ~21.8%. With New Zealand margin essentially flat at ~67%, the group mix is leaning harder on the home market for profit growth.
• Leverage direction is clearly positive. Net debt dropped from $22.1m to $11.8m and equity expanded to $331.7m. This gives the balance sheet more capacity even as statutory earnings remain thin.

Expectations

No quantified FY26 revenue, EBITDA, or forward-work target is disclosed in the supplied materials, and no ARR-to-revenue conversion target is given. ARR grew 6.1% to $175.1m, which is broadly in line with reported revenue growth and does not point to a visible acceleration. H1 contributed 49.3% of full-year revenue and 49.0% of EBITDA, so the shape was only marginally second-half weighted at the top line. H1 NPAT was -$1.5m, meaning the full $1.4m NPAT was effectively earned in H2 — a thin base on which to extrapolate.

Quality of result

PBT is the cleaner read here given the statutory tax rate is highly distorted (effective tax benefit versus a $0.2m PBT base), and on that measure the $7.2m swing from a $7.0m loss to break-even is the real operating read. However, the quality question concentrates below EBITDA:

• The $14.7m uplift in FCF is almost entirely a capex story, not a cash-earnings story.
• Working capital helped modestly, with trade receivables flat at $25.3m and receivable days improving from 50.7 to 47.5, but this is too small to explain the OCF decline — some of the EBITDA-to-cash gap sits elsewhere in working capital or non-cash items that are not fully decomposed in the supplied extracts.
• NPAT of $1.4m is heavily tax-assisted; the underlying PBT of $0.2m is effectively break-even.

The durable elements are the leverage reduction and New Zealand segment stability. The timing-assisted elements are the FCF print and the NPAT print.

Unresolved

• Is the $13.4m capex level a new steady-state, or will investment step back up after the 4G upgrade program fully concludes? The difference between $13.4m and $32.2m is larger than reported FCF.
• Why did OCF fall $9.7m while EBITDA rose $6.3m? The supplied data flags improved receivable days but does not reconcile the remaining gap.
• What drove the North America EBITDA margin compression from ~27.5% to ~21.8%, and is it mix, pricing, or cost-base?
• Corporate & Development losses of $31.6m remain a structural drag; the release does not set out a path or timeline for narrowing them.
• Dividend details are not quantified in the supplied extraction, so payout intent and coverage against the $16.0m FCF cannot be judged.
• This briefing cannot assess valuation, share-price reaction, or any FY26 guidance commentary not present in the supplied materials.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.